Bitget App
Trade smarter
Acheter des cryptosMarchésTradingFuturesEarnCommunautéPlus
Prix
Données
À propos
RMD stock price forecast
Actualités
Concurrents
Tokenisation
Crypto
FAQ
Logo action ResMed Inc.

ResMed Inc.

RMD·NYSE

Dernière mise à jour : 2026-02-12 23:13 EST. Les données sur les prix des actions proviennent de TradingView et reflètent les prix du marché en temps réel.

Insights
Calculateur
Actualités

Variation du cours des actions RMD

Le dernier jour de trading, l'action RMD a clôturé à 255.18 USD, avec une variation de prix de -1.71% pour la journée.
Trader des Futures sur actions

À propos de Bitget

La première plateforme d'échange (UEX) au monde, permettant aux utilisateurs de trader non seulement des cryptomonnaies, mais aussi des actions, des ETF, le Forex, l'or et des actifs du monde réel (RWA).
En savoir plus

RMD – Données clés

Clôture précédente255.18 USD
Capitalisation37.17B USD
Volume184.80K
Ratio P/E25.22
Rendement du dividende (sur 12 mois)0.87%
Montant du dividende0.60 USD
Dernière date de détachementNov 13, 2025
Date du dernier paiementDec 18, 2025
BPA dilué (sur 12 mois)10.12 USD
Résultat net (ex. financier)1.40B USD
Chiffre d'affaires (ex. financier)5.15B USD
Date du prochain rapportApr 23, 2026
Estimation du BPA2.810 USD
Chiffre d'affaires estimé1.42B USD USD
Actions en circulation144.66M
Bêta (1Y)0.67
Tokenized stocks

Avez-vous déjà entendu parler des actions tokenisées ?

Une nouvelle façon de trader des actions – n'importe où, 24h/7j

En savoir plus

ResMed Inc. – Vue d'ensemble

ResMed, Inc. propose des technologies de santé numérique et des dispositifs médicaux connectés au cloud. Ses technologies de santé numérique et dispositifs médicaux connectés transforment la prise en charge des personnes souffrant d’apnée du sommeil, de maladie pulmonaire obstructive chronique (MPOC) et d’autres maladies chroniques. L’entreprise opère à travers les segments Sleep and Respiratory Care et Software as a Service. Le segment Sleep and Respiratory Care intervient dans le secteur des troubles du sommeil et respiratoires de l’industrie des dispositifs médicaux. Le segment Software as a Service fournit des logiciels de gestion d’entreprise en tant que service aux prestataires de santé hors hôpital. La société a été fondée par Peter C. Farrell en juin 1989 et son siège social est situé à San Diego, Californie.
Secteur
Technologie de la santé
Secteur d'activité
Spécialités médicales
CEO
Michael J. Farrell
Siège social
San Diego
Site web
resmed.com
Création
1989
Employés (ex. financier)
10.6K
Variation (1 an)
+620 +6.21%
Chiffre d'affaires / Employé (1Y)
485.50K USD
Résultat net / Employé (1Y)
132.14K USD

Baromètre RMD en temps réel

Daily updates on RMD stock prices, fund flows, and market news, generated by AI and reviewed by our team of analysts. Always DYOR.

• Variation du cours de l’action RMD sur 24h : -3,26 %. De 259,61 USD à 251,15 USD. Ce recul s’explique principalement par une vente massive sur le secteur de la santé et des prises de bénéfices après le rallye des résultats de fin janvier.
• D’un point de vue technique, RMD affiche une « structure haussière sous pression à court terme » : bien que le titre reste au-dessus de ses moyennes mobiles sur 50 et 200 jours (SMA50 à ~$261, SMA200 à ~$254), la baisse récente a fait reculer le RSI sur 14 jours à 68, quittant ainsi la zone de surachat. Le titre teste actuellement un support proche du seuil psychologique des $250.
• ResMed a publié d’excellents résultats au deuxième trimestre 2026, avec une hausse du chiffre d’affaires de 11 % à 1,42 milliard de dollars et une marge brute élargie à 62,6 %, dépassant les attentes des analystes tant sur le chiffre d’affaires que sur le bénéfice.
• La société a annoncé un dividende trimestriel de $0,60 par action (date d’enregistrement : 12 février) et confirmé l’achèvement de son programme de rachat d’actions de $1,19 milliard, soulignant une politique de capital favorable aux actionnaires.
• ResMed a récemment obtenu l’autorisation de la FDA pour les paramètres de thérapie personnalisée « Smart Comfort », une technologie basée sur l’IA conçue pour améliorer l’adhésion des patients aux traitements CPAP.
• Le marché mondial des équipements médicaux durables (DME) devrait croître de 5 à 7 % d’ici 2029, porté par le vieillissement de la population et l’intégration de l’IoT et de la télésurveillance dans les soins respiratoires.
• Les perspectives santé 2026 de J.P. Morgan soulignent que la medtech pilotée par l’IA et l’intégration numérique seront les principaux moteurs de la surperformance du secteur et des opérations de fusions-acquisitions cette année.
Voir plus
il y a 12h
• Variation du cours de l'action RMD sur 24h : -2,56 %. De 275,96 USD à 268,88 USD. Ce repli fait suite à une période de fortes hausses après les bons résultats de fin janvier, les investisseurs ayant pris leurs bénéfices et réagi à la récente vente d’environ 5 000 actions par le PDG.
• D’un point de vue technique, le titre est en « forte consolidation haussière » : les principales moyennes mobiles (MA10, MA50, MA200) indiquent une tendance fortement positive, tandis que le RSI à 68,7 suggère un rapprochement de la zone de surachat. Le support est solide autour de 252 $, avec une résistance majeure proche du plus haut sur 52 semaines à 293,81 $.
• Le PDG de ResMed, Michael Farrell, a vendu 4 991 actions le 9 février à un prix moyen de 273,78 $, selon les derniers dépôts auprès de la SEC, tout en conservant plus de 466 000 actions.
• L’entreprise a déclaré un dividende trimestriel de 0,60 $ par action, avec une date de détachement fixée au 12 février 2026, maintenant ainsi sa politique de retour de capital favorable aux actionnaires.
• ResMed a confirmé l’achèvement de son programme de rachat d’actions pluriannuel de 1,19 milliard de dollars, après un solide deuxième trimestre fiscal 2026 marqué par une croissance du chiffre d’affaires de 11 % et une expansion significative des marges.
• Selon les perspectives Vizient Winter 2026, l’inflation de la chaîne d’approvisionnement en santé devrait augmenter de 2,78 % d’ici juin 2027, les coûts informatiques et d’infrastructures dépassant désormais les dépenses pharmaceutiques.
• Le Congrès américain a finalisé le financement fédéral pour l’exercice 2026, prolongeant les principales flexibilités en télésanté jusqu’en décembre 2027, une mesure qui soutient la croissance à long terme des secteurs de la santé numérique et de la télésurveillance.
Voir plus
il y a 1j

RMD stock price forecast

According to technical indicators for RMD stock, the price is likely to fluctuate within the range of 268.27–314.36 USD over the next week. Market analysts predict that the price of RMD stock will likely fluctuate within the range of 259.88–368.28 USD over the next months.

Based on 1-year price forecasts from 85 analysts, the highest estimate is 477.98 USD, while the lowest estimate is 185.66 USD.

For more information, please see the RMD stock price forecast Stock Price Forecast page.

Avec un simple compte Bitget, vous pouvez trader simultanément des actions et des cryptomonnaies.

Participer maintenant

FAQ

Quel est le cours de l'action ResMed Inc. ?

RMD a actuellement un prix de 255.18 USD. Son cours a varié de -1.71% au cours des dernières 24h. Vous pouvez suivre de plus près l'évolution du cours de l'action ResMed Inc. sur le graphique de prix en haut de cette page.

Quel est le symbole boursier de ResMed Inc. ?

Selon la plateforme, le symbole boursier peut varier. Par exemple, sur NYSE, ResMed Inc. est tradé sous le symbole RMD.

Quelles sont les prévisions pour les actions RMD ?

Nous avons recueilli des avis d'analystes sur le cours futur de ResMed Inc.. Selon leurs prévisions, RMD a une estimation maximale de 2551.80 USD et une estimation minimale de 510.36 USD.

Quelle est la capitalisation boursière de ResMed Inc. ?

ResMed Inc. a une capitalisation boursière de 37.17B USD.

What is P/E ratio (TTM)?

The P/E ratio (TTM) stands for price-to-earnings ratio (trailing twelve months). It is a historical valuation metric calculated using a company's earnings per share (EPS) over the most recent twelve consecutive months, reflecting the company's past profitability.

The P/E ratio measures the relationship between a stock's price and a company's profitability, and is often used as a basis for judging whether a stock is "cheap" or "expensive."

P/E ratio = market price (P) ÷ earnings per share (EPS), or P/E ratio = total market capitalization ÷ net profit attributable to shareholders

The interpretation of the P/E ratio (TTM) should always be considered alongside other factors and is mainly used for valuation comparisons rather than as a standalone indicator.

  • A lower P/E ratio (TTM) means investors are paying less for each unit of earnings. This may indicate that the stock is undervalued, or that the market has limited expectations for the company's future growth, such as in mature or slow-growing industries.
  • A higher P/E ratio (TTM) means investors are paying more for each unit of earnings. This often reflects expectations of strong future earnings growth, which is common among growth or technology stocks, though it may also suggest the stock is overvalued.
  • Comparison with peers: Compare the company's P/E (TTM) with the average or median P/E of other companies in the same industry. A significantly higher P/E may require further analysis to determine whether the company's high valuation is justified by stronger growth prospects or competitive advantages.
  • Comparison with historical levels: Compare the company's current P/E (TTM) with its own historical average (such as over the past 5 or 10 years) to assess whether the current valuation is at a historical high or low.
  • Comparison with the broader market: Compare the company's P/E (TTM) with major market indices (such as the S&P 500) to see how the market is valuing the company overall.

P/E ratios can vary widely across industries, and there is no single "ideal" P/E level. A reasonable P/E range depends on the industry, the company's growth potential, and the broader macroeconomic environment. Investment decisions should not rely solely on the P/E ratio (TTM) but should be based on a comprehensive analysis that includes company quality, growth prospects, and financial health.

Can I trade stocks on Bitget?

You can trade stocks on Bitget, but mainly through stock tokens and stock perps, rather than by directly buying or selling traditional stocks.

This approach reflects Bitget's vision as a Universal Exchange (UEX), designed to connect traditional financial markets with cryptocurrency markets.

Bitget currently offers the following stock-related trading formats:

1. Stock tokens (spot)

Nature: Stock tokens are digital tokens pegged to the price of specific traditional stocks (such as TSLAUSDT and NVDAUSDT) and are traded on Bitget's spot market.

Features: When you trade stock tokens, you are buying and holding tokens rather than owning the underlying traditional stocks.

  • The price of these tokens generally follows the price movements of the stocks they are pegged to, such as Tesla or Nvidia.
  • The advantage is that you can participate in the price movements of traditional financial assets, such as U.S. stocks, using cryptocurrencies (for example, USDT), without the need for a traditional brokerage account.

2. Stock perps

Nature: Bitget also offers USDT-margined perpetual futures, commonly referred to as stock perps, based on major U.S. blue-chip stocks such as Tesla and Meta.

Characteristics: Stock perps are derivative products that allow you to take a bullish or bearish view on the future price of an underlying stock through margin trading. These products typically support leverage, such as up to 25x.

It does not involve owning the underlying stock. Instead, profits and losses are settled based on price movements of the futures.

Important note: When trading stock perps on Bitget, you are participating in derivative markets within the cryptocurrency ecosystem. This is fundamentally different from purchasing publicly traded shares through a traditional brokerage, as you do not own equity in the underlying company.

Futures trading and the use of leverage involve high risk. Please ensure you fully understand the risks before trading.

If you wish to directly hold equity in traditional stocks and enjoy shareholder rights (such as receiving dividends), you must trade through a regulated traditional securities brokerage or brokerage platform.

What are the advantages of Bitget's stock perps?

Bitget's stock perps—typically perpetual futures based on stock tokens prices—are an innovative offering that allows cryptocurrency platforms to provide exposure to traditional financial markets.

Compared to traditional stock or futures trading, they offer several unique advantages, primarily due to the platform's trading infrastructure.

Bitget's stock perps, typically USDT-denominated derivatives, offer the following key advantages:

1. Trading convenience and global accessibility

  • 24/7 trading: Traditional stock markets, such as U.S. equity markets, operate during fixed trading hours. In contrast, cryptocurrency derivatives markets are typically open 24/7. This means investors can trade anytime, capitalizing on breaking news or market fluctuations.
  • Lower entry barriers and faster onboarding: Compared with traditional brokerages, which often require extensive identity verification and lengthy account setup processes, Bitget generally offers faster account onboarding. Users can trade using cryptocurrencies such as USDT, without the need for complex fiat deposit and withdrawal procedures.
  • Global accessibility: Users can access derivatives trading linked to globally recognized stocks via the Bitget platform, subject to applicable regulations.

2. Capital efficiency and high leverage

  • High leverage options: Stock perps typically offer higher leverage than traditional stock trading (for example, up to 25x). This allows traders to control larger positions with smaller margin requirements, improving capital efficiency.
    Note: While high leverage can amplify gains, it also amplifies losses proportionally.
  • Two-way trading: Traders can easily take both long and short positions. This means traders can potentially profit from market volatility whether stock prices rise or fall, provided the market direction is correctly anticipated.

3. Trading and settlement using cryptocurrency

  • USDT margin: Stock perps on Bitget typically use USDT (or other stablecoins) as the margin and settlement currency. For users who already hold cryptocurrency, there is no need to convert assets into fiat currency, allowing them to trade directly with stablecoins.
  • Efficient fund transfers: Crypto-based transfers and settlements are typically faster than traditional fiat systems, enabling more efficient global fund allocation.

4. Integration

One-stop platform: Bitget allows users to trade spot cryptocurrencies, crypto derivatives, and stock perps on a single platform, making it easier to manage different asset types in one place.

Avertissement sur les risques:

While Bitget's stock perps offer several advantages, it is important to understand the associated risks.

  • High leverage risk: Leveraged trading can result in rapid loss of your entire margin.
  • No equity ownership: When trading stock perps, you do not own the underlying shares. As a result, you are not entitled to dividends or voting rights.
  • Market liquidity risk: Tokenized stock perps may have lower liquidity than their counterparts in traditional stock markets, especially outside regular trading hours.

In summary, Bitget's stock perps offer advantages such as greater trading flexibility, lower entry barriers, and higher capital efficiency.

What are the trading fees for Bitget stock perps?

Trading fees for Bitget stock perps (USDT-margined perpetual futures) mainly include transaction fees and funding rates.

Transaction fees:

Bitget offers limited-time fee promotions for stock perps (especially tokenized stock perps) from time to time to attract traders.

Standard reference rates: Under Bitget's standard futures fee structure, the taker fee is typically around 0.06%, while the maker fee is around 0.02%.

Current promotions for stock perps (important): To promote its stock perps products, Bitget is offering discounted transaction fees during Q4 2025, with taker fees as low as 0.006% and maker fees as low as 0.002%. There is also a limited-time promotion offering zero-fee trading for spot stock tokens.

Recommandation : les activités promotionnelles pouvant être modifiées ou interrompues à tout moment, veuillez consulter les pages officielles " Fee overview " ou " Announcement Center " de Bitget pour connaître les taux les plus récents et les plus précis au moment du trading.

Funding rate:

The funding rate is a key mechanism in perpetual futures (including stock perps) that helps keep the futures price closely aligned with the spot price of the underlying asset. It is not a fee charged by the platform, but a periodic payment exchanged between long and short traders.

Funding rates fluctuate dynamically and are mainly driven by market sentiment and imbalances between long and short positions. Stock perps generally experience lower volatility than cryptocurrencies, so funding rates are often relatively low during stable market conditions. However, during earnings seasons or major positive or negative news events, heavy concentration of long or short positions—such as in high-growth technology stocks like Tesla or Nvidia—can create significant imbalances, causing funding rates to spike in the short term.

Funding payments are typically settled every 8 hours. If you close your position before the funding settlement time, no funding payment will be charged or received.

Funding rates are not fixed. If you hold a position for an extended period, high positive funding rates (for long positions) or high negative funding rates (for short positions) will affect your overall holding costs or potential returns. For this reason, it is important to monitor the funding rate in real time on the trading interface.

NYSE/
RMD
Bitget© 2026